Serum chemokine CXCL8 as a better biomarker for diagnosis and prediction of pancreatic cancer than its specific receptor CXCR2, C-reactive protein, and classic tumor markers CA 19-9 and CEA

Ala
Litman-Zawadzka
Marta
Łukaszewicz-Zając
Mariusz
Gryko
Agnieszka
Kulczyńska-Przybik
Barbara
Mroczko
Pol Arch Intern Med
2018
128
9
524
531
Published online: 
July 27, 2018

tabs-grup